Sellersville, PA, September 21, 2020: Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing Organization (CDMO), held a grand opening event at their recently acquired solid oral dosage drug product manufacturing facility located in Sellersville, Pennsylvania.
Peter DeYoung, Chief Executive Officer, Piramal Pharma Solutions, addressed the guests remotely and explained that this acquisition broadens the offering of Piramal Pharma Solutions by adding solid oral dosage form capabilities (tablets and capsules) in North America. He stated, “This is a big day for us. We are rapidly growing and we take pride in the fact that we let our customer’s guide how and where we grow. The Sellersville facility is a great example of this. It was acquired because it addresses a market need for solid oral dosage form development and manufacturing in the United States. It also gives us new capabilities in liquids, creams, and ointments. As a leading CDMO offering end-to-end solutions across the drug life cycle, it’s vital that we provide our customers with a complete suite of services in all major geographies.”
Robert Harvie, Vice Chair of Bucks County Commissioners, spoke to the audience and welcomed PPS to the area. “Founded more than 350 years ago, this county has attracted people and businesses from all over the world because of its location and resources. We’re proud to still be attracting businesses like Piramal Pharma Solutions, which provides employment and economic benefits to our residents and produces valuable medicines that can quickly get to the people who need them.” Thomas Hufnagle, Mayor of Sellersville Borough, said, “It did my heart good to come here this morning and see the full parking lot at this site. It’s clear that this company is looking to building for the future, which makes this a great day.”
John Fowler, Chief Operating Officer, Piramal Pharma Solutions, also addressed the audience. Mr. Fowler stated, “Bringing the Sellersville site into the family significantly helps us accomplish our goal of getting medicines to patients. This is the thirteenth facility in our global network and our first solid dose facility in North America, giving us critical mass that matches local market need.” Stuart Needleman, Chief Commercial Officer, Piramal Pharma Solutions, added, “As a patient-centric organization, our mission is to help our customers reduce the burden of disease on patients. It’s the reason why we get up in the morning. And the Sellersville site most definitely enhances our ability to do that.”
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.